Target intelligence / Profile preview

Carboxypeptidase N subunit 2 (CPN2)

Target
CPN2
Molecular classification
Enzyme (regulatory subunit), Metalloprotease complex (as part of carboxypeptidase N)
01

Overview

Carboxypeptidase N subunit 2 is the high molecular weight, 83 kDa regulatory subunit of the plasma metalloprotease carboxypeptidase N. This subunit binds and stabilizes the smaller, enzymatically active subunits (CPN1), enabling their proper function in the bloodstream. CPN2 plays a crucial role in the regulation of peptide hormones and anaphylatoxins by maintaining carboxypeptidase N activity, which in turn modulates inflammation and innate immune responses. CPN2 itself does not perform catalytic cleavage, but by stabilizing and possibly allosterically modifying CPN1, it indirectly influences the breakdown of peptides such as complement anaphylatoxins and kinins. Note: The molecule is not a receptor, but a regulatory subunit of an enzyme complex important in inflammation and immune regulation. There are no common direct inhibitors or therapeutically approved drugs that target CPN2 specifically; zinc functions as a cofactor for the enzyme complex. Disease roles are mostly inferred from its involvement in inflammation and immune system pathways. If more specific therapeutic targeting emerges in future research, these roles may be updated. Currently, CPN2 is best considered a regulatory enzyme subunit within the broader carboxypeptidase N complex.

Other names
ACBPCarboxypeptidase N 83 kDa chainCarboxypeptidase N large subunitCarboxypeptidase N polypeptide 2Carboxypeptidase N regulatory subunit
02

Mechanism of action

Enzyme stabilization (drug cofactors maintain protein stability and activity); Not directly inhibited or modulated by currently approved drugs

03

Biological functions

Protein stabilization (of catalytic subunit)Enzyme regulator activity (allosteric and protective)Regulation of complement cascadeInflammation regulation
04

Disease associations

InflammationImmune disorders (as part of complement and kinin regulation)Toxic pneumonitisOther roles in innate immune system
05

Safety considerations

Potential off-target effects in complement pathway regulationRedundant function in carboxypeptidase family may complicate specific targetingPossible disruption of immune homeostasis if inhibited
06

Interacting drugs

Zinc salts (cofactor, but not true inhibitors or agonists; zinc acetate, zinc chloride, zinc sulfate)

1 more in the full profile.

07

Biomarkers

Potential use in monitoring immune response or complement activity in disease (limited direct biomarker evidence)

Beyond the preview

Go deeper on Carboxypeptidase N subunit 2 (CPN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carboxypeptidase N subunit 2 (CPN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call